Biora Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Biora Therapeutics

30/03/2023 22:40

* Biora Therapeutics Inc  BIOR.OQ  reported a quarterly
adjusted
loss of $1.64​​ per share for the quarter ended in December. The
mean expectation of two analysts for the quarter was for a loss
of $1.44 per share.
    * Revenue fell 96.8% to $14.00 thousand from a year ago;
analysts
expected $55.00 thousand. 
    * Biora Therapeutics Inc's reported EPS for the quarter was
a loss
of $1.64​.
    * The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Biora Therapeutics Inc shares had fallen by 19.5% this
quarter.
    * The company reported a quarterly loss of $13.72 million.
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $82.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 30 at 09:40 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.44          -1.64          Missed
 Sep. 30 2022      -1.87          -0.75          Beat
 Jun. 30 2022      -3.00          -0.75          Beat
 Mar. 31 2022      -3.12          -2.00          Beat